Overheard at Frequency

The Overheard at Frequency podcast explores issues surrounding hearing loss and the unmet needs of the patient community. Hosted by Colleen Chapman, Senior Director of Patient Advocacy and Government Affairs at Frequency Therapeutics, the podcast brings timely and interesting stories about hearing science, advocacy and innovation to our listeners.

In episode 5, Colleen sits down with Gael Hannan and Shari Eberts, co-authors of Hear & Beyond: Live Skillfully with Hearing Loss, a new book that has been described as the “ultimate survival guide” for people living with hearing loss. Their conversation breaks down some of the many tips offered in the book. Visit hearandbeyond.com to learn more.

The Overheard at Frequency podcast explores issues surrounding hearing loss and the unmet needs of the patient community. Hosted by Colleen Chapman, Senior Director of Patient Advocacy and Government Affairs at Frequency Therapeutics, the podcast brings timely and interesting stories about hearing science, advocacy and innovation to our listeners.

In episode 4, Colleen sits down with Dr. Nicholas Reed, hearing health care researcher at the Cochlear Center for Hearing and Public Health at Johns Hopkins University. Dr. Reed combines his backgrounds in audiology and epidemiology to study urgent issues of quality and cost of healthcare for people with hearing loss, and this discussion touches upon that critical work. Dr. Reed also shares his vision for the future of shifting hearing health care from acute care to precision medicine.

The Overheard at Frequency podcast explores issues surrounding hearing loss and the unmet needs of the patient community. Hosted by Colleen Chapman, Senior Director of Patient Advocacy and Government Affairs at Frequency Therapeutics, the podcast brings timely and interesting stories about hearing science, advocacy and innovation to our listeners.

In part 2 of this two-part episode, Colleen sits down with Carl LeBel, PhD, Frequency’s Chief Development Officer, to discuss news from Frequency’s Research & Development Event on November 9th, 2021, including pooled data from FX-322 studies and a new hearing restoration candidate, FX-345.

Those interested in watching Frequency’s R&D Event may do so at this link: https://investors.frequencytx.com/2021_Virtual_R-D_Event 

The Overheard at Frequency podcast explores issues surrounding hearing loss and the unmet needs of the patient community. Hosted by Colleen Chapman, Senior Director of Patient Advocacy and Government Affairs at Frequency Therapeutics, the podcast brings timely and interesting stories about hearing science, advocacy and innovation to our listeners.

In part 1 of this two-part episode, Colleen sits down with Carl LeBel, PhD, Frequency’s Chief Development Officer, to discuss a new clinical study of FX-322 that is currently enrolling subjects, new learnings from previous studies and how we are incorporating those learnings into ongoing and future trials – all with the goal of potentially bringing the first hearing loss therapeutic to patients.

The Overheard at Frequency podcast explores issues surrounding hearing loss and the unmet needs of the patient community. Hosted by Colleen Chapman, Senior Director of Patient Advocacy and Government Affairs at Frequency Therapeutics, the podcast brings timely and interesting stories about hearing science, advocacy and innovation to patients.

In episode 2, Colleen sits down with Barbara Kelley, Executive Director of the Hearing Loss Association of America (HLAA). They talk about the prevalence of hearing loss among people aged 50 or younger and the impact it has on lives and careers, the roots of hearing loss advocacy as a self-empowerment movement and the changes Barbara envisions for the future.

To watch the FDA’s Externally-Led Patient Focused Drug Development Meeting for People and Families with Sensorineural Hearing Loss (referenced in this episode), visit: https://www.hearingloss.org/hlaa-pfdd/

The Overheard at Frequency podcast explores issues surrounding hearing loss and the unmet needs of the patient community. Hosted by Colleen Chapman, Senior Director of Patient Advocacy and Government Affairs at Frequency Therapeutics, the podcast brings timely and interesting stories about hearing science, advocacy and innovation to patients.

In episode 1, Colleen sits down with Kevin Franck, PhD, Senior Vice President of Strategic Marketing and New Product Planning at Frequency, to cover three topics: the world of hearing health from the perspective of an audiologist, the push toward restorative therapies and the critical role patient advocacy plays in health care and health policy.